Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.13 | 0.7 |
mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |